Whole Exome Sequencing reveals NOTCH1 mutations in anaplastic large cell lymphoma and points to Notch both as a key pathway and a potential therapeutic target.

MLA

Larose, Hugo, et al. “Whole Exome Sequencing Reveals NOTCH1 Mutations in Anaplastic Large Cell Lymphoma and Points to Notch Both as a Key Pathway and a Potential Therapeutic Target.” Haematologica, vol. 106, no. 6, June 2021, pp. 1693–704. EBSCOhost, https://doi.org/10.3324/haematol.2019.238766.

APA

Larose, H., Prokoph, N., Matthews, J. D., Schlederer, M., Högler, S., Alsulami, A. F., Ducray, S. P., Nuglozeh, E., Fazaludeen, F. M. S., Elmouna, A., Ceccon, M., Mologni, L., Gambacorti-Passerini, C., Hoefler, G., Lobello, C., Pospisilova, S., Janikova, A., Woessmann, W., Damm-Welk, C., … Turner, S. D. (2021). Whole Exome Sequencing reveals NOTCH1 mutations in anaplastic large cell lymphoma and points to Notch both as a key pathway and a potential therapeutic target. Haematologica, 106(6), 1693–1704. https://doi.org/10.3324/haematol.2019.238766

Chicago

Larose, Hugo, Nina Prokoph, Jamie D Matthews, Michaela Schlederer, Sandra Högler, Ali F Alsulami, Stephen P Ducray, et al. 2021. “Whole Exome Sequencing Reveals NOTCH1 Mutations in Anaplastic Large Cell Lymphoma and Points to Notch Both as a Key Pathway and a Potential Therapeutic Target.” Haematologica 106 (6): 1693–1704. doi:10.3324/haematol.2019.238766.